XML 18 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Jun. 27, 2020
Jun. 29, 2019
Operating activities:    
Net earnings $ 11,721,000 $ 68,752,000
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation of property, plant and equipment 37,353,000 33,374,000
Amortization of intangibles and deferred costs 2,516,000 2,586,000
Share-based compensation 3,421,000 3,006,000
Deferred income taxes (426,000) 690,000
Loss on marketable securities 1,746,000 410,000
Plant shutdown impairment costs 5,072,000 0
Other (309,000) 350,000
Changes in assets and liabilities net of effects from purchase of companies    
Decrease (increase) in accounts receivable 24,634,000 (14,289,000)
Increase in inventories (3,751,000) (6,257,000)
(Increase) decrease in prepaid expenses (7,879,000) 957,000
(Decrease) increase in accounts payable and accrued liabilities (7,478,000) 11,584,000
Net cash provided by operating activities 66,620,000 101,163,000
Investing activities:    
Payment for purchases of companies, net of cash acquired (57,197,000) (1,155,000)
Purchases of property, plant and equipment (47,637,000) (42,136,000)
Purchases of marketable securities (6,103,000) (24,056,000)
Proceeds from redemption and sales of marketable securities 54,125,000 29,721,000
Proceeds from disposal of property, plant and equipment 2,852,000 1,463,000
Other (72,000) (212,000)
Net cash used in investing activities (54,032,000) (36,375,000)
Financing activities:    
Payments to repurchase common stock (8,972,000) 0
Proceeds from issuance of stock 6,300,000 7,426,000
Payments on capitalized lease obligations (272,000) (33,000)
Payment of cash dividend (31,193,000) (27,230,000)
Net cash used in financing activities (34,137,000) (19,837,000)
Effect of exchange rate on cash and cash equivalents (885,000) (333,000)
Net (decrease) increase in cash and cash equivalents (22,434,000) 44,618,000
Cash and cash equivalents at beginning of period 192,395,000 111,479,000
Cash and cash equivalents at end of period $ 169,961,000 $ 156,097,000